Works matching IS 15257304 AND DT 2009 AND VI 10 AND IP 4


Results: 20
    1
    2
    3
    4
    5

    Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

    Published in:
    Clinical Lung Cancer, 2009, v. 10, n. 4, p. 252, doi. 10.3816/CLC.2009.n.035
    By:
    • Patel, Jyoti D.;
    • Bonomi, Philip;
    • Socinski, Mark A.;
    • Govindan, Ramaswamy;
    • Hong, Shengyan;
    • Obasaju, Coleman;
    • Pennella, Eduardo J.;
    • Girvan, Allicia C.;
    • Guba, Susan C.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    CLINICAL Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2009, v. 10, n. 4, p. 210
    By:
    • CIG Media Group
    Publication type:
    Article
    13
    14
    15
    16
    17

    A Decade of Clinical Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2009, v. 10, n. 4, p. 216, doi. 10.3816/CLC.2009.n.028
    By:
    • Gandara, David R.;
    • Simons, Jasper
    Publication type:
    Article
    18
    19
    20